{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:48:39Z","timestamp":1768992519481,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T00:00:00Z","timestamp":1380067200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2474-14-279","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T13:23:02Z","timestamp":1380115382000},"source":"Crossref","is-referenced-by-count":12,"title":["Patient\u2019s access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal"],"prefix":"10.1186","volume":"14","author":[{"given":"Pedro A","family":"Laires","sequence":"first","affiliation":[]},{"given":"Rui","family":"Mesquita","sequence":"additional","affiliation":[]},{"given":"Lu\u00eds","family":"Veloso","sequence":"additional","affiliation":[]},{"given":"Ana Paula","family":"Martins","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Cernadas","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Eurico","family":"Fonseca","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,9,25]]},"reference":[{"key":"1908_CR1","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0140-6736(01)06075-5","volume":"358","author":"DM Lee","year":"2001","unstructured":"Lee DM, Weinblatt ME: Rheumatoid arthritis. Lancet. 2001, 358: 903-911. 10.1016\/S0140-6736(01)06075-5.","journal-title":"Lancet"},{"key":"1908_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00019053-200422001-00002","volume":"22","author":"TK Kvien","year":"2004","unstructured":"Kvien TK: Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics. 2004, 22: 1-12.","journal-title":"Pharmacoeconomics"},{"key":"1908_CR3","doi-asserted-by":"crossref","first-page":"S09","DOI":"10.18553\/jmcp.2011.17.s9-b.S09","volume":"17","author":"K Farheen","year":"2011","unstructured":"Farheen K, Agarwal SK: Assessment of disease activity and treatment outcomes in rheumatoid arthritis. J Manag Care Pharm. 2011, 17: S09-13.","journal-title":"J Manag Care Pharm"},{"key":"1908_CR4","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1002\/art.20351","volume":"50","author":"M Korpela","year":"2004","unstructured":"Korpela M, Laasonen L, Hannonen P, Kautiainen H, Leirisalo-Repo M, Hakala M, Paimela L, Bl\u00e5field H, Puolakka K, Puolakka T: Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum. 2004, 50: 2072-2081. 10.1002\/art.20351.","journal-title":"Arthritis Rheum"},{"key":"1908_CR5","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1093\/rheumatology\/keh199","volume":"43","author":"VPK Nell","year":"2004","unstructured":"Nell VPK, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS: Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2004, 43: 906-914. 10.1093\/rheumatology\/keh199.","journal-title":"Rheumatology (Oxford)"},{"key":"1908_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9","volume":"43","author":"JJ Anderson","year":"2000","unstructured":"Anderson JJ, Wells G, Verhoeven AC, Felson DT: Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 2000, 43: 22-29. 10.1002\/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9.","journal-title":"Arthritis Rheum"},{"key":"1908_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/ard.2005.044354","volume":"66","author":"B Combe","year":"2007","unstructured":"Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, Emery P, Ferraccioli G, Hazes JMW, Klareskog L, Machold K, Martin-Mola E, Nielsen H, Silman A, Smolen J, Yazici H: EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007, 66: 34-45.","journal-title":"Ann Rheum Dis"},{"key":"1908_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/rheumatology\/kep340","volume":"49","author":"B Fautrel","year":"2010","unstructured":"Fautrel B, Benhamou M, Foltz V, Rincheval N, Rat AC, Combe B, Berenbaum F, Bourgeois P, Guillemin F: Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort. Rheumatology (Oxford). 2010, 49: 147-155. 10.1093\/rheumatology\/kep340.","journal-title":"Rheumatology (Oxford)"},{"key":"1908_CR9","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1093\/rheumatology\/kem130","volume":"46","author":"K Kumar","year":"2007","unstructured":"Kumar K, Daley E, Carruthers DM, Situnayake D, Gordon C, Grindulis K, Buckley CD, Khattak F, Raza K: Delay in presentation to primary care physicians is the main reason why patients with rheumatoid arthritis are seen late by rheumatologists. Rheumatology (Oxford). 2007, 46: 1438-1440. 10.1093\/rheumatology\/kem130.","journal-title":"Rheumatology (Oxford)"},{"key":"1908_CR10","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/art.1780370606","volume":"37","author":"KW Chan","year":"1994","unstructured":"Chan KW, Felson DT, Yood RA, Walker AM: The lag time between onset of symptoms and diagnosis of rheumatoid arthritis. Arthritis Rheum. 1994, 37: 814-820. 10.1002\/art.1780370606.","journal-title":"Arthritis Rheum"},{"key":"1908_CR11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01720610-201110000-00005","volume":"24","author":"LJ Sekhon","year":"2011","unstructured":"Sekhon LJ: Using the new ACR criteria for early diagnosis of rheumatoid arthritis. JAAPA. 2011, 24: 32-35. 58","journal-title":"JAAPA"},{"key":"1908_CR12","volume-title":"Access to innovative treatments in rheumatoid arthritis in Europe. A report prepared for the European Federation of Pharmaceutical Industry Associations (EFPIA)","author":"G Kobelt","year":"2009","unstructured":"Kobelt G, Kasteng F: Access to innovative treatments in rheumatoid arthritis in Europe. A report prepared for the European Federation of Pharmaceutical Industry Associations (EFPIA). 2009"},{"key":"1908_CR13","volume-title":"Eur J Health Econ","author":"PA Laires","year":"2012","unstructured":"Laires PA, Exposto F, Mesquita R, Martins AP, Cunha Miranda L, Fonseca JE: Patients\u2019 access to biologics in rheumatoid arthritis: a comparison between Portugal and other European countries. Eur J Health Econ. 2012, doi:10.1007\/s10198-012-0432-5"},{"key":"1908_CR14","volume-title":"A Survey of Barriers to Treatment Access in Rheumatoid Arthritis in France, Germany, Italy, Spain and UK","author":"C Miltenburger","year":"2009","unstructured":"Miltenburger C, Gunther O, Justo N: A Survey of Barriers to Treatment Access in Rheumatoid Arthritis in France, Germany, Italy, Spain and UK. 2009"},{"key":"1908_CR15","volume-title":"Qualitative research methods a data collector\u2019s field guide","author":"N Mack","year":"2005","unstructured":"Mack N, Woodsong C, Family Health International: Qualitative research methods a data collector\u2019s field guide. 2005, North Carolina: FLI USAID"},{"key":"1908_CR16","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1136\/ard.2009.117341","volume":"69","author":"B Saleem","year":"2010","unstructured":"Saleem B, Keen H, Goeb V, Parmar R, Nizam S, Hensor EMA, Churchman SM, Quinn M, Wakefield R, Conaghan PG, Ponchel F, Emery P: Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?. Ann Rheum Dis. 2010, 69: 1636-1642. 10.1136\/ard.2009.117341.","journal-title":"Ann Rheum Dis"},{"key":"1908_CR17","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1002\/art.27692","volume":"62","author":"D Van","year":"2010","unstructured":"Van D, Linden MPM, Le Cessie S, Raza K, Van Der Woude D, Knevel R, Huizinga TWJ, Van Der H, Van Mil AHM: Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheuma. 2010, 62: 3537-3546. 10.1002\/art.27692.","journal-title":"Arthritis Rheuma"},{"key":"1908_CR18","first-page":"45","volume":"36","author":"H Canh\u00e3o","year":"2011","unstructured":"Canh\u00e3o H, Faustino A, Martins F, Fonseca JE: Reuma.pt - the rheumatic diseases portuguese register. Acta Reumatol Port. 2011, 36: 45-56.","journal-title":"Acta Reumatol Port"},{"key":"1908_CR19","first-page":"384","volume":"35","author":"S Ramiro","year":"2010","unstructured":"Ramiro S, Canh\u00e3o H, Branco JC: EpiReumaPt Protocol - Portuguese epidemiologic study of the rheumatic diseases. Acta Reumatol Port. 2010, 35: 384-390.","journal-title":"Acta Reumatol Port"},{"key":"1908_CR20","first-page":"18","volume":"37","author":"PA Laires","year":"2012","unstructured":"Laires PA, Canh\u00e3o H, Ara\u00fajo D, Fonseca JE, Machado P, Mour\u00e3o AF, Ramiro S, Romeu JC, Santos MJ, Silva I, Silva JA, Sousa E, Tavares V, Gouveia N, Branco JC: CoReumaPt protocol: the Portuguese cohort of rheumatic diseases. Acta Reumatol Port. 2012, 37: 18-24.","journal-title":"Acta Reumatol Port"},{"key":"1908_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.amjmed.2008.09.030","volume":"122","author":"SL Silverman","year":"2009","unstructured":"Silverman SL: From randomized controlled trials to observational studies. Am J Med. 2009, 122: 114-120. 10.1016\/j.amjmed.2008.09.030.","journal-title":"Am J Med"},{"key":"1908_CR22","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/rheumatology\/kes184","volume":"51","author":"H Canhao","year":"2012","unstructured":"Canhao H, Rodrigues AM, Mourao AF, Martins F, Santos MJ, Canas Silva J, Polido Pereira J, Pereira Silva JA, Costa JA, Ara\u00fajo D, Silva C, Santos H, Duarte C, da Silva JAP, Pimentel Santos FM, Branco JC, Karlson EW, Fonseca JE, Solomon DH: Comparative effectiveness and predictors of response to tumour necrosis factor inhibitor therapies in rheumatoid arthritis. Rheumatology (Oxford). 2012, 51: 2020-2026. 10.1093\/rheumatology\/kes184.","journal-title":"Rheumatology (Oxford)"},{"key":"1908_CR23","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.autrev.2011.04.023","volume":"10","author":"J Polido-Pereira","year":"2011","unstructured":"Polido-Pereira J, Vieira-Sousa E, Fonseca JE: Rheumatoid arthritis: what is refractory disease and how to manage it?. Autoimmun Rev. 2011, 10: 707-713. 10.1016\/j.autrev.2011.04.023.","journal-title":"Autoimmun Rev"},{"key":"1908_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.2217\/ijr.12.37","volume":"7","author":"SC Horton","year":"2012","unstructured":"Horton SC, Nam JL, Buch MH: Safety of biologics in rheumatoid arthritis. Int J Clin Rheumatol. 2012, 7: 425-451. 10.2217\/ijr.12.37.","journal-title":"Int J Clin Rheumatol"},{"key":"1908_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van\u2019t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 44-48. 10.1002\/art.1780380107.","journal-title":"Arthritis Rheum"},{"key":"1908_CR26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.rdc.2005.09.005","volume":"32","author":"D Aletaha","year":"2006","unstructured":"Aletaha D, Smolen JS: The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin North Am. 2006, 32: 9-44. 10.1016\/j.rdc.2005.09.005. vii","journal-title":"Rheum Dis Clin North Am"},{"key":"1908_CR27","first-page":"385","volume":"36","author":"JE Fonseca","year":"2011","unstructured":"Fonseca JE, Bernardes M, Canh\u00e3o H, Santos MJ, Quintal A, Malcata A, Neto A, Cordeiro A, Rodrigues A, Mour\u00e3o AF, Ribeiro AS, Cravo AR, Barcelos A, Cardoso A, Vilar A, Bra\u00f1a A, Faustino A, Silva C, Duarte C, Ara\u00fajo D, Nour D, Sousa E, Sim\u00f5es E, Godinho F, Brand\u00e3o F, Ventura F, Sequeira G, Figueiredo G, Cunha I, Matos JA: Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 update. Acta Reumatol Port. 2011, 36: 385-388.","journal-title":"Acta Reumatol Port"},{"key":"1908_CR28","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1471-2474-13-200","volume":"13","author":"H Lempp","year":"2012","unstructured":"Lempp H, Hofmann D, Hatch SL, Scott DL: Patients\u2019 views about treatment with combination therapy for Rheumatoid Arthritis: a comparative qualitative study. BMC Musculoskelet Disord. 2012, 13: 200-10.1186\/1471-2474-13-200.","journal-title":"BMC Musculoskelet Disord"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-14-279.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-14-279\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-14-279","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T21:44:46Z","timestamp":1646603086000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-14-279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1908"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-14-279","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,25]]},"article-number":"279"}}